| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP BCL9L ABL1 LAMA1 DACT2 DAG1 CC2D1A PLXND1 BAP1 TAOK2 PTPRD PTPRS PKHD1 FGFR3 CAMSAP1 NYAP1 WASF1 PLXNA1 PLXNB1 GP1BA BRWD1 VHL WHRN SEMA4F HSPG2 NPR2 CUX2 DOCK10 ID1 CCDC88C SIDT2 CELSR3 CELSR2 TNN RIMS1 RIMS2 TNR | 1.72e-08 | 1194 | 231 | 37 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP ABL1 LAMA1 DAG1 CC2D1A PLXND1 TAOK2 PTPRD PTPRS FGFR3 NYAP1 WASF1 PLXNA1 PLXNB1 SEMA4F HSPG2 NPR2 CUX2 DOCK10 ID1 CELSR3 CELSR2 TNN RIMS1 RIMS2 TNR | 1.24e-06 | 802 | 231 | 26 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP ABL1 LAMA1 DAG1 CC2D1A PLXND1 TAOK2 PTPRD PTPRS FGFR3 NYAP1 WASF1 PLXNA1 PLXNB1 SEMA4F HSPG2 NPR2 CUX2 DOCK10 ID1 CELSR3 CELSR2 TNN RIMS1 RIMS2 TNR | 1.82e-06 | 819 | 231 | 26 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP ABL1 LAMA1 DAG1 CC2D1A PLXND1 TAOK2 PTPRD PTPRS FGFR3 NYAP1 WASF1 PLXNA1 PLXNB1 SEMA4F HSPG2 NPR2 CUX2 DOCK10 ID1 CELSR3 CELSR2 TNN RIMS1 RIMS2 TNR | 2.13e-06 | 826 | 231 | 26 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP ABL1 KIF26A LAMA1 DAG1 CC2D1A PLXND1 TAOK2 PTPRD PTPRS FGFR3 CAMSAP1 NYAP1 WASF1 PLXNA1 PLXNB1 WHRN SEMA4F HSPG2 NPR2 CUX2 GPR37 DOCK10 ID1 CELSR3 CELSR2 TNN CSPG4 CNTN3 RIMS1 RIMS2 TNR TNXB VPS13B | 2.64e-06 | 1285 | 231 | 34 | GO:0031175 |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 1.34e-05 | 28 | 231 | 5 | GO:0060445 | |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP ABL1 PDGFB KIF26A LAMA1 DAG1 CC2D1A PLXND1 TAOK2 PTPRD PTPRS FGFR3 CAMSAP1 NYAP1 WASF1 PLXNA1 PLXNB1 WHRN SEMA4F HSPG2 NPR2 CUX2 GPR37 DOCK10 ID1 CELSR3 CELSR2 TNN CSPG4 CNTN3 RIMS1 RIMS2 TNR TNXB VPS13B | 1.67e-05 | 1463 | 231 | 35 | GO:0048666 |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP ABL1 PDGFB SPTBN2 DAG1 CC2D1A PLXND1 CSMD2 PCDH17 TAOK2 PTPRD PTPRS WASF1 PLXNB1 VHL CABP1 CUX2 DOCK10 SORBS1 RIMS2 TNR | 3.15e-05 | 685 | 231 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ABL1 LAMA1 DAG1 CC2D1A PLXND1 TAOK2 PTPRD PTPRS FGFR3 PLXNA1 PLXNB1 WHRN SEMA4F HSPG2 NPR2 CUX2 DOCK10 ID1 CELSR3 CELSR2 TNN TNR | 3.79e-05 | 748 | 231 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 4.69e-05 | 7 | 231 | 3 | GO:0150037 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 6.26e-05 | 38 | 231 | 5 | GO:0007435 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | ABL1 PDGFB DAG1 SMOC2 TAOK2 PKD1 PKHD1 KIF14 SGCE SORBS1 SNED1 RELL2 TNN TNXB MADCAM1 | 6.42e-05 | 410 | 231 | 15 | GO:0031589 |
| GeneOntologyBiologicalProcess | cell growth | DAB2IP ABL1 KIF26A RPS6KA3 BAP1 TAOK2 CISH PTPRS KIF14 WASF1 PLXNA1 SEMA4F EGLN2 NPR2 C10orf90 TNN RIMS1 RIMS2 TNR | 8.46e-05 | 625 | 231 | 19 | GO:0016049 |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP ABL1 PDGFB SPTBN2 DAG1 CC2D1A PLXND1 CSMD2 PCDH17 TAOK2 PTPRD PTPRS PKHD1 WASF1 PLXNB1 VHL WHRN CABP1 CUX2 FBF1 DOCK10 SORBS1 RIMS2 TNR TNS1 | 1.01e-04 | 974 | 231 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | salivary gland development | 1.15e-04 | 43 | 231 | 5 | GO:0007431 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ERBB3 PDE3B ABL1 PDGFB PIEZO1 LAMA1 DACT2 DAG1 PLXND1 SMOC2 ITPKB TAOK2 PKD1 PKHD1 KIF14 PLXNA1 PLXNB1 GP1BA HSPG2 CELSR2 RELL2 TNN TNR TNXB | 1.23e-04 | 927 | 231 | 24 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at postsynapse | 1.57e-04 | 10 | 231 | 3 | GO:0140252 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | BCL9L DAG1 PLXND1 TAOK2 PTPRD CAMSAP1 PLXNA1 PLXNB1 BRWD1 CUX2 RIMS1 RIMS2 | 1.63e-04 | 302 | 231 | 12 | GO:0022604 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | ABL1 PDGFB SPINT1 LAMA1 DAG1 PLXND1 PKD1 PKHD1 PLXNA1 SETD2 CELSR1 | 1.66e-04 | 258 | 231 | 11 | GO:0001763 |
| GeneOntologyBiologicalProcess | dichotomous subdivision of an epithelial terminal unit | 2.14e-04 | 11 | 231 | 3 | GO:0060600 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | DAB2IP STARD13 BCL9L PDE3B ABL1 DAG1 PLXND1 SMOC2 TAOK2 PTPRD PTPRS PKHD1 CAMSAP1 PLXNA1 PLXNB1 BRWD1 SEMA4F HSPG2 CUX2 ID1 RUNX2 CELSR1 TNN RIMS1 RIMS2 TNR | 2.34e-04 | 1090 | 231 | 26 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ABL1 PDGFB BCAS3 SPTBN2 APC2 MCM2 NAA80 TAOK2 PTPRD PTPRS RECQL4 PKD1 FGFR3 CAMSAP1 WASF1 RAB5A PLXNB1 PIF1 NPR2 ARHGEF5 WASHC1 ID1 C10orf90 PLEKHG2 CCDC88C WASH3P CELSR1 RIMBP2 RIMS1 RIMS2 | 2.34e-04 | 1342 | 231 | 30 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | ABL1 DAG1 TAOK2 PKD1 PKHD1 SGCE SORBS1 SNED1 TNN TNXB MADCAM1 | 2.46e-04 | 270 | 231 | 11 | GO:0007160 |
| GeneOntologyBiologicalProcess | double-strand break repair via break-induced replication | 2.83e-04 | 12 | 231 | 3 | GO:0000727 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ABL1 BCAS3 SPTBN2 APC2 NAA80 TAOK2 PKD1 CAMSAP1 WASF1 PLXNB1 ARHGEF5 WASHC1 ID1 PLEKHG2 CCDC88C WASH3P CELSR1 | 3.01e-04 | 579 | 231 | 17 | GO:0051493 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | ABL1 PDGFB SPINT1 LAMA1 DAG1 PLXND1 PKD1 PKHD1 PLXNA1 CELSR1 | 3.44e-04 | 236 | 231 | 10 | GO:0061138 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ABL1 SPINT1 LAMA1 DAG1 SMOC2 VHL HSPG2 OLFML2B WASHC1 FURIN ADAMTS14 TNR TNXB | 3.49e-04 | 377 | 231 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ABL1 SPINT1 LAMA1 DAG1 SMOC2 VHL HSPG2 OLFML2B WASHC1 FURIN ADAMTS14 TNR TNXB | 3.58e-04 | 378 | 231 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 3.65e-04 | 13 | 231 | 3 | GO:0031632 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 3.65e-04 | 13 | 231 | 3 | GO:1901634 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 3.65e-04 | 13 | 231 | 3 | GO:0099502 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ABL1 SPINT1 LAMA1 DAG1 SMOC2 VHL HSPG2 OLFML2B WASHC1 FURIN ADAMTS14 TNR TNXB | 3.67e-04 | 379 | 231 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 3.72e-04 | 55 | 231 | 5 | GO:0060071 | |
| GeneOntologyBiologicalProcess | central nervous system development | DAB2IP ABL1 KIF26A RPS6KA3 SPTBN2 DAG1 PHF8 KDM6B TTBK1 PTPRS GLI1 TPP1 NR0B1 KIF14 FGFR3 PLXNA1 WHRN HSPG2 SRSF1 ID3 SETD2 CELSR1 CELSR2 MAST1 SNTG2 TNR VPS13B | 4.27e-04 | 1197 | 231 | 27 | GO:0007417 |
| GeneOntologyBiologicalProcess | exocrine system development | 4.40e-04 | 57 | 231 | 5 | GO:0035272 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | ABL1 SPTBN2 APC2 NAA80 CAMSAP1 WASF1 HSPG2 ARHGEF5 WASHC1 ID1 PLEKHG2 CCDC88C WASH3P TNXB | 4.47e-04 | 438 | 231 | 14 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at synapse | 4.61e-04 | 14 | 231 | 3 | GO:0140250 | |
| GeneOntologyBiologicalProcess | angiogenesis involved in wound healing | 5.46e-04 | 34 | 231 | 4 | GO:0060055 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 5.58e-04 | 60 | 231 | 5 | GO:0021587 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 5.63e-04 | 207 | 231 | 9 | GO:1990138 | |
| GeneOntologyBiologicalProcess | motor neuron migration | 5.71e-04 | 15 | 231 | 3 | GO:0097475 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SPTBN2 DAG1 CC2D1A PLXND1 CSMD2 PCDH17 TAOK2 PTPRD PTPRS RAB5A PLXNA1 VHL CABP1 SEMA4F DOCK10 GRIK4 TRIM3 CELSR3 EIF4EBP1 PRKAR1B SORCS3 RIMBP2 RIMS1 RIMS2 TNR KLHL17 | 1.36e-06 | 817 | 231 | 26 | GO:0098978 |
| GeneOntologyCellularComponent | tenascin complex | 5.28e-06 | 4 | 231 | 3 | GO:0090733 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.09e-05 | 17 | 231 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 9.09e-05 | 22 | 231 | 4 | GO:0031258 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.51e-04 | 10 | 231 | 3 | GO:0097539 | |
| GeneOntologyCellularComponent | glycoprotein complex | 1.53e-04 | 25 | 231 | 4 | GO:0090665 | |
| GeneOntologyCellularComponent | postsynapse | ERBB3 ABL1 SPTBN2 APC2 DAG1 CSMD2 PCDH17 TAOK2 PTPRS SORCS2 WASF1 RAB5A VHL WHRN CABP1 SEMA4F DOCK10 GRIK4 TRIM3 CELSR3 EIF4EBP1 PRKAR1B SORCS3 RIMS1 KLHL17 | 1.63e-04 | 1018 | 231 | 25 | GO:0098794 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 3.51e-04 | 13 | 231 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | cell leading edge | ABL1 GBF1 BCAS3 PDLIM7 PIEZO1 APC2 DAG1 PLXND1 SGCE WASF1 RAB5A WASHC1 WASH3P RAB34 CSPG4 | 4.75e-04 | 500 | 231 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | extracellular matrix | PDGFB LAMA1 DAG1 SMOC2 GP1BA HSPG2 FRAS1 CILP OLFML2B SNED1 RELL2 TNN CSPG4 ADAMTS14 TNR MUC5AC TNXB | 1.05e-03 | 656 | 231 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | PDGFB LAMA1 DAG1 SMOC2 GP1BA HSPG2 FRAS1 CILP OLFML2B SNED1 RELL2 TNN CSPG4 ADAMTS14 TNR MUC5AC TNXB | 1.08e-03 | 658 | 231 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 1.32e-03 | 20 | 231 | 3 | GO:0016010 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.34e-03 | 109 | 231 | 6 | GO:0005796 | |
| MousePheno | abnormal digestive system morphology | ERBB3 ABL1 TTLL3 KIF26A MCM2 MCM4 RCBTB2 PLXND1 SMOC2 MBD6 FHIP1B GCNT4 BAP1 ITPKB EHBP1L1 FDX2 RECQL4 PKD1 PKHD1 FGFR3 WASF1 HSPG2 FRAS1 NPR2 RHBDF1 SMCHD1 KHDRBS2 FNDC4 RUNX2 MLXIPL MISP RAB34 CELSR3 BAZ1A FURIN MUC5AC | 4.02e-06 | 1233 | 184 | 36 | MP:0000462 |
| Domain | Qua1_dom | 1.70e-06 | 3 | 224 | 3 | IPR032571 | |
| Domain | Sam68-YY | 1.70e-06 | 3 | 224 | 3 | IPR032335 | |
| Domain | Sam68-YY | 1.70e-06 | 3 | 224 | 3 | PF16568 | |
| Domain | Qua1 | 1.70e-06 | 3 | 224 | 3 | PF16274 | |
| Domain | Ig-like_fold | SPEG DAG1 PLXND1 KIRREL2 PTPRD PTPRS PKHD1 FGFR3 ADGRF3 KIR2DL4 PLXNA1 PLXNB1 HSPG2 TRIM2 CILP FNDC4 TRIM3 SNED1 TNN CNTN3 RIMBP2 TNR TNXB MADCAM1 | 4.53e-06 | 706 | 224 | 24 | IPR013783 |
| Domain | - | SPEG DAG1 PLXND1 KIRREL2 PTPRD PTPRS PKHD1 FGFR3 KIR2DL4 PLXNA1 PLXNB1 HSPG2 TRIM2 CILP FNDC4 TRIM3 SNED1 TNN CNTN3 RIMBP2 TNR TNXB MADCAM1 | 5.20e-06 | 663 | 224 | 23 | 2.60.40.10 |
| Domain | LAM_G_DOMAIN | 5.58e-06 | 38 | 224 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 7.60e-06 | 40 | 224 | 6 | PF02210 | |
| Domain | LamG | 1.34e-05 | 44 | 224 | 6 | SM00282 | |
| Domain | EGF_LAM_2 | 2.65e-05 | 30 | 224 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 2.65e-05 | 30 | 224 | 5 | PS01248 | |
| Domain | fn3 | 2.66e-05 | 162 | 224 | 10 | PF00041 | |
| Domain | GPS | 4.97e-05 | 34 | 224 | 5 | SM00303 | |
| Domain | EGF_Lam | 5.75e-05 | 35 | 224 | 5 | SM00180 | |
| Domain | GPS | 5.75e-05 | 35 | 224 | 5 | PF01825 | |
| Domain | Laminin_EGF | 5.75e-05 | 35 | 224 | 5 | PF00053 | |
| Domain | PKD | 5.75e-05 | 7 | 224 | 3 | PF00801 | |
| Domain | GPS | 6.61e-05 | 36 | 224 | 5 | PS50221 | |
| Domain | Laminin_G | 6.69e-05 | 58 | 224 | 6 | IPR001791 | |
| Domain | GPS | 7.57e-05 | 37 | 224 | 5 | IPR000203 | |
| Domain | FN3 | 8.19e-05 | 185 | 224 | 10 | SM00060 | |
| Domain | Laminin_EGF | 8.63e-05 | 38 | 224 | 5 | IPR002049 | |
| Domain | Growth_fac_rcpt_ | 1.13e-04 | 156 | 224 | 9 | IPR009030 | |
| Domain | Plexin_cytopl | 1.36e-04 | 9 | 224 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.36e-04 | 9 | 224 | 3 | IPR013548 | |
| Domain | Plexin | 1.36e-04 | 9 | 224 | 3 | IPR031148 | |
| Domain | FN3 | 1.50e-04 | 199 | 224 | 10 | PS50853 | |
| Domain | FN3_dom | 2.23e-04 | 209 | 224 | 10 | IPR003961 | |
| Domain | GAIN_dom_N | 2.62e-04 | 11 | 224 | 3 | IPR032471 | |
| Domain | PKD | 2.62e-04 | 11 | 224 | 3 | PS50093 | |
| Domain | PKD_dom | 2.62e-04 | 11 | 224 | 3 | IPR000601 | |
| Domain | Laminin_G_1 | 2.62e-04 | 11 | 224 | 3 | PF00054 | |
| Domain | GAIN | 2.62e-04 | 11 | 224 | 3 | PF16489 | |
| Domain | - | 2.62e-04 | 11 | 224 | 3 | 2.60.40.670 | |
| Domain | IPT | 2.85e-04 | 27 | 224 | 4 | SM00429 | |
| Domain | PDZ | 3.05e-04 | 141 | 224 | 8 | PF00595 | |
| Domain | HRM | 3.29e-04 | 28 | 224 | 4 | PF02793 | |
| Domain | PDZ | 4.23e-04 | 148 | 224 | 8 | SM00228 | |
| Domain | CADG | 4.26e-04 | 3 | 224 | 2 | SM00736 | |
| Domain | Cadg | 4.26e-04 | 3 | 224 | 2 | IPR006644 | |
| Domain | - | 4.62e-04 | 150 | 224 | 8 | 2.30.42.10 | |
| Domain | PDZ | 4.83e-04 | 151 | 224 | 8 | PS50106 | |
| Domain | Semap_dom | 4.91e-04 | 31 | 224 | 4 | IPR001627 | |
| Domain | SEMA | 4.91e-04 | 31 | 224 | 4 | PS51004 | |
| Domain | TIG | 4.91e-04 | 31 | 224 | 4 | PF01833 | |
| Domain | Sema | 4.91e-04 | 31 | 224 | 4 | SM00630 | |
| Domain | Sema | 4.91e-04 | 31 | 224 | 4 | PF01403 | |
| Domain | PDZ | 5.05e-04 | 152 | 224 | 8 | IPR001478 | |
| Domain | IPT | 5.56e-04 | 32 | 224 | 4 | IPR002909 | |
| Domain | Plexin_repeat | 5.56e-04 | 32 | 224 | 4 | IPR002165 | |
| Domain | PSI | 5.56e-04 | 32 | 224 | 4 | PF01437 | |
| Domain | EGF | 5.63e-04 | 235 | 224 | 10 | SM00181 | |
| Domain | DNA-bd_prot-inh | 8.46e-04 | 4 | 224 | 2 | IPR026052 | |
| Domain | Post-SET_dom | 8.49e-04 | 16 | 224 | 3 | IPR003616 | |
| Domain | PostSET | 8.49e-04 | 16 | 224 | 3 | SM00508 | |
| Domain | POST_SET | 8.49e-04 | 16 | 224 | 3 | PS50868 | |
| Domain | EGF-like_dom | 8.79e-04 | 249 | 224 | 10 | IPR000742 | |
| Domain | - | 9.95e-04 | 95 | 224 | 6 | 2.60.120.200 | |
| Domain | Furin_repeat | 1.22e-03 | 18 | 224 | 3 | IPR006212 | |
| Domain | FU | 1.22e-03 | 18 | 224 | 3 | SM00261 | |
| Domain | GPCR_2_extracellular_dom | 1.31e-03 | 40 | 224 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.31e-03 | 40 | 224 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.31e-03 | 40 | 224 | 4 | PS50227 | |
| Domain | AWS | 1.40e-03 | 5 | 224 | 2 | SM00570 | |
| Domain | Sortilin_C | 1.40e-03 | 5 | 224 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.40e-03 | 5 | 224 | 2 | PF15902 | |
| Domain | AWS | 1.40e-03 | 5 | 224 | 2 | PS51215 | |
| Domain | VPS10 | 1.40e-03 | 5 | 224 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.40e-03 | 5 | 224 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.40e-03 | 5 | 224 | 2 | IPR031777 | |
| Domain | AWS_dom | 1.40e-03 | 5 | 224 | 2 | IPR006560 | |
| Domain | VPS10 | 1.40e-03 | 5 | 224 | 2 | SM00602 | |
| Domain | BROMODOMAIN_2 | 1.44e-03 | 41 | 224 | 4 | PS50014 | |
| Domain | Bromodomain | 1.58e-03 | 42 | 224 | 4 | IPR001487 | |
| Domain | BROMO | 1.58e-03 | 42 | 224 | 4 | SM00297 | |
| Domain | - | 1.58e-03 | 42 | 224 | 4 | 1.20.920.10 | |
| Domain | Ig_E-set | 1.59e-03 | 104 | 224 | 6 | IPR014756 | |
| Domain | PSI | 1.88e-03 | 44 | 224 | 4 | IPR016201 | |
| Domain | MCM_N | 2.08e-03 | 6 | 224 | 2 | PF14551 | |
| Domain | MCM_CS | 2.08e-03 | 6 | 224 | 2 | IPR018525 | |
| Domain | MCM_N | 2.08e-03 | 6 | 224 | 2 | IPR027925 | |
| Domain | WxxW_domain | 2.08e-03 | 6 | 224 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.08e-03 | 6 | 224 | 2 | PF13330 | |
| Domain | Ig_I-set | 2.12e-03 | 190 | 224 | 8 | IPR013098 | |
| Domain | I-set | 2.12e-03 | 190 | 224 | 8 | PF07679 | |
| Domain | PSI | 2.22e-03 | 46 | 224 | 4 | SM00423 | |
| Domain | Cadherin-like | 2.76e-03 | 116 | 224 | 6 | IPR015919 | |
| Domain | Fibrinogen_a/b/g_C_2 | 2.86e-03 | 24 | 224 | 3 | IPR014715 | |
| Domain | WH2 | 2.86e-03 | 24 | 224 | 3 | PS51082 | |
| Domain | - | 2.86e-03 | 24 | 224 | 3 | 4.10.530.10 | |
| Domain | 7tm_2 | 3.01e-03 | 50 | 224 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 3.01e-03 | 50 | 224 | 4 | PS00650 | |
| Domain | HormR | 3.22e-03 | 25 | 224 | 3 | SM00008 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 1.75e-05 | 5 | 172 | 3 | M27731 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 1.75e-05 | 5 | 172 | 3 | MM15481 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.84e-05 | 76 | 172 | 7 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.33e-05 | 84 | 172 | 7 | M7098 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION | 9.56e-05 | 8 | 172 | 3 | M47840 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 1.58e-04 | 23 | 172 | 4 | M48234 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP ABL1 GBF1 KIF26A BCAS3 SPEG PIEZO1 CC2D1A PLXND1 KDM6B MBD6 FHIP1B BAP1 TAOK2 EHBP1L1 PTPRS GLI1 RRP12 IFRD2 PKD1 CAMSAP1 PLXNA1 SEMA4F HSPG2 CRYBG2 FRAS1 RHBDF1 RASSF7 ANO8 CCDC88C CELSR1 CELSR3 CELSR2 FURIN CSPG4 SNAPC4 KLHL17 | 2.27e-15 | 1105 | 241 | 37 | 35748872 |
| Pubmed | 2.29e-15 | 12 | 241 | 8 | 10433963 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 5.59e-15 | 8 | 241 | 7 | 17588759 | |
| Pubmed | 5.91e-15 | 13 | 241 | 8 | 17668377 | ||
| Pubmed | 8.29e-14 | 10 | 241 | 7 | 17984056 | ||
| Pubmed | 1.16e-12 | 13 | 241 | 7 | 7739628 | ||
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 1.29e-11 | 17 | 241 | 7 | 11245978 | |
| Pubmed | A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. | 2.17e-08 | 44 | 241 | 7 | 32492419 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L ERBB3 GBF1 NCL TRIP12 KIF14 FGFR3 CAMSAP1 PRRC2A SMCHD1 FBF1 CELSR3 KHDRBS1 BAZ1A | 2.73e-07 | 361 | 241 | 14 | 26167880 |
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 11677057 | ||
| Pubmed | Inhibition of HIV-1 gene expression by Sam68 Delta C: multiple targets but a common mechanism? | 3.29e-07 | 3 | 241 | 3 | 19254361 | |
| Pubmed | Mapping of determinants involved in the stimulation of HIV-1 expression by Sam68. | 3.29e-07 | 3 | 241 | 3 | 19091369 | |
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 11568184 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 31805436 | ||
| Pubmed | SPTBN2 PLXND1 TRIP12 TAOK2 RRP12 WHRN KIAA1549 SORBS1 CELSR3 | 3.37e-07 | 130 | 241 | 9 | 12421765 | |
| Pubmed | KIF26A BCAS3 KIRREL2 HSPA12B FDX2 TSGA10IP WHRN GARIN5B SEMA4F DUX4 MAST1 | 7.91e-07 | 233 | 241 | 11 | 37704626 | |
| Pubmed | STARD13 SPINT1 PDLIM7 ASH1L PSMD8 TRIP12 CISH PKD1 CAMSAP1 VHL HSPG2 EGLN2 PPL UBXN11 KHDRBS1 BAZ1A CSPG4 | 9.63e-07 | 591 | 241 | 17 | 15231748 | |
| Pubmed | DAB2IP SPTBN2 APC2 NCL TAOK2 PTPRD PTPRS CAMSAP1 WASF1 PRRC2A GOLGA1 SRSF1 SORBS1 TRIM3 CCDC88C CELSR2 PRKAR1B RIMBP2 RIMS1 FRMPD3 TNR TNS1 | 1.17e-06 | 963 | 241 | 22 | 28671696 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 15471878 | ||
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 1.31e-06 | 4 | 241 | 3 | 38509386 | |
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 1.31e-06 | 4 | 241 | 3 | 37224017 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 17911620 | ||
| Pubmed | SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. | 1.31e-06 | 4 | 241 | 3 | 22196734 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 20421204 | ||
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 1.31e-06 | 4 | 241 | 3 | 11850187 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDE3B ABL1 GBF1 BCAS3 STXBP4 CC2D1A TRIP12 ITPKB KIF14 KMT2A BOD1L1 CAMSAP1 ARHGEF5 SORBS1 PLEKHG2 RASSF7 CCDC88C MLXIPL CEP89 PROSER2 | 2.84e-06 | 861 | 241 | 20 | 36931259 |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 10077576 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 18287524 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 33539324 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 3.25e-06 | 5 | 241 | 3 | 11701968 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 37770450 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 32755572 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 24029645 | ||
| Pubmed | Centriole distal appendages promote membrane docking, leading to cilia initiation. | 3.25e-06 | 5 | 241 | 3 | 23348840 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 20063414 | ||
| Pubmed | 3.83e-06 | 16 | 241 | 4 | 16880404 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDE3B SPTBN2 LAMA1 NCL PHF8 CSMD2 TRIP12 PCDH17 NUP205 RECQL4 PKD1 PKHD1 BOD1L1 GP1BA SEMA4F GPR37 PITPNM3 TNR | 4.49e-06 | 736 | 241 | 18 | 29676528 |
| Pubmed | KIF26A PIEZO1 MCM2 PLXND1 KDM6B BAP1 NUP205 TAOK2 CACNA1G PLXNB1 SMCHD1 FBF1 KIAA1549 CELSR3 RIMS2 | 5.04e-06 | 529 | 241 | 15 | 14621295 | |
| Pubmed | DAB2IP SPEG PHF8 FHIP1B RRP12 BOD1L1 WHRN FRAS1 DOCK10 SORBS1 MAST1 RIMBP2 VPS13B | 6.16e-06 | 407 | 241 | 13 | 12693553 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 6.47e-06 | 6 | 241 | 3 | 18159949 | |
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 6.47e-06 | 6 | 241 | 3 | 21126580 | |
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 6.47e-06 | 6 | 241 | 3 | 30758284 | |
| Pubmed | Dynamic expression of the RNA-binding protein Sam68 during mouse pre-implantation development. | 6.47e-06 | 6 | 241 | 3 | 18321792 | |
| Pubmed | Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. | 6.47e-06 | 6 | 241 | 3 | 12529443 | |
| Pubmed | How to Make an Active Zone: Unexpected Universal Functional Redundancy between RIMs and RIM-BPs. | 6.47e-06 | 6 | 241 | 3 | 27537484 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 1.13e-05 | 7 | 241 | 3 | 17937400 | |
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 1.13e-05 | 7 | 241 | 3 | 30765463 | |
| Pubmed | 1.38e-05 | 257 | 241 | 10 | 30945288 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.62e-05 | 208 | 241 | 9 | 33230847 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GBF1 STXBP4 RPS6KA3 MCM2 MCM4 CC2D1A PSMD8 NCL NUP205 PTPRD PTPRS TSEN34 PRRC2A RAB5A SLC27A3 SRSF1 SMCHD1 PUSL1 PPL RAB34 | 1.72e-05 | 974 | 241 | 20 | 28675297 |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 1.79e-05 | 8 | 241 | 3 | 10655549 | |
| Pubmed | 1.79e-05 | 8 | 241 | 3 | 16899510 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.90e-05 | 79 | 241 | 6 | 18757743 | |
| Pubmed | BCL9L ABL1 SRMS MCM4 FANCD2OS NCL FGFR3 CAMSAP1 PRRC2A VHL DDX31 | 2.30e-05 | 332 | 241 | 11 | 37433992 | |
| Pubmed | 2.51e-05 | 83 | 241 | 6 | 9039502 | ||
| Pubmed | 2.68e-05 | 9 | 241 | 3 | 10846177 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 2.98e-05 | 26 | 241 | 4 | 17124501 | |
| Pubmed | Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos. | 2.98e-05 | 26 | 241 | 4 | 37228654 | |
| Pubmed | 2.98e-05 | 26 | 241 | 4 | 26735018 | ||
| Pubmed | 3.05e-05 | 52 | 241 | 5 | 26633812 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | ERF RPS6KA3 NCL EHBP1L1 PTPRD SGCE MBD2 PIF1 VHL EGLN2 NPR2 SRSF1 CEP164 ANO8 MLXIPL WASH3P MISP CSPG4 PITPNM3 WASH2P | 3.34e-05 | 1021 | 241 | 20 | 26760575 |
| Pubmed | Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures. | 4.78e-05 | 2 | 241 | 2 | 29741619 | |
| Pubmed | The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. | 4.78e-05 | 2 | 241 | 2 | 18439897 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 37976977 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 25636209 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 20333247 | ||
| Pubmed | RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction. | 4.78e-05 | 2 | 241 | 2 | 25240052 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 23836919 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 10790539 | ||
| Pubmed | MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. | 4.78e-05 | 2 | 241 | 2 | 29777171 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 14978793 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 12858547 | ||
| Pubmed | Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains. | 4.78e-05 | 2 | 241 | 2 | 12559962 | |
| Pubmed | A role for Id proteins in mammary gland physiology and tumorigenesis. | 4.78e-05 | 2 | 241 | 2 | 15530557 | |
| Pubmed | Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. | 4.78e-05 | 2 | 241 | 2 | 26758068 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 11919560 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 29462330 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 17851550 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 19647517 | ||
| Pubmed | Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2. | 4.78e-05 | 2 | 241 | 2 | 26002201 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 21213369 | ||
| Pubmed | Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. | 4.78e-05 | 2 | 241 | 2 | 15368360 | |
| Pubmed | Fluid shear stress induces Runx-2 expression via upregulation of PIEZO1 in MC3T3-E1 cells. | 4.78e-05 | 2 | 241 | 2 | 32181967 | |
| Pubmed | RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes. | 4.78e-05 | 2 | 241 | 2 | 29606581 | |
| Pubmed | PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2. | 4.78e-05 | 2 | 241 | 2 | 20939912 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 20181926 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 20191379 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 18190532 | ||
| Pubmed | Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. | 4.78e-05 | 2 | 241 | 2 | 16271072 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 21486943 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 23311395 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 33938911 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 15342397 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 16475793 | ||
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 18519801 | ||
| Pubmed | Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2. | 4.78e-05 | 2 | 241 | 2 | 30281091 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 23771884 | ||
| Pubmed | Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism. | 4.78e-05 | 2 | 241 | 2 | 33784257 | |
| Pubmed | 4.78e-05 | 2 | 241 | 2 | 14734633 | ||
| Pubmed | RIM genes differentially contribute to organizing presynaptic release sites. | 4.78e-05 | 2 | 241 | 2 | 22753485 | |
| Interaction | TOP3B interactions | DAB2IP ABL1 GBF1 KIF26A BCAS3 SPEG PIEZO1 SPTBN2 CC2D1A PLXND1 KDM6B MBD6 FHIP1B BAP1 TAOK2 EHBP1L1 PTPRS GLI1 RRP12 IFRD2 PKD1 KIF14 CAMSAP1 PRRC2A PLXNA1 SEMA4F HSPG2 CRYBG2 FRAS1 RHBDF1 RASSF7 ANO8 CCDC88C CELSR1 CELSR3 CELSR2 FURIN CSPG4 SNAPC4 KLHL17 | 2.08e-07 | 1470 | 229 | 40 | int:TOP3B |
| Interaction | MPDZ interactions | BAP1 RECQL4 KIF14 FGFR3 WASF1 GPR37 SMCHD1 CCDC88C POLR1D CSPG4 | 3.96e-07 | 107 | 229 | 10 | int:MPDZ |
| Interaction | TMEM30B interactions | 5.58e-06 | 85 | 229 | 8 | int:TMEM30B | |
| Interaction | SIRPD interactions | 6.09e-06 | 86 | 229 | 8 | int:SIRPD | |
| Interaction | YWHAH interactions | DAB2IP PDE3B ABL1 GBF1 BCAS3 SPEG STXBP4 RPS6KA3 MCM2 CC2D1A TRIP12 BAP1 RECQL4 KIF14 KMT2A BOD1L1 CAMSAP1 WASF1 SRSF1 ARHGEF5 SORBS1 PLEKHG2 RASSF7 CCDC88C MLXIPL CEP89 MAST1 RIMS1 PROSER2 RIMS2 | 8.27e-06 | 1102 | 229 | 30 | int:YWHAH |
| Interaction | SDF2L1 interactions | RNF130 NAAA SPINT1 MCM2 BAP1 FGFR3 RAB5A PLXNA1 HSPG2 FRAS1 ANPEP FUT11 CELSR1 CSPG4 | 2.04e-05 | 322 | 229 | 14 | int:SDF2L1 |
| Interaction | GGH interactions | NAAA DAG1 MCM2 TRIP12 EHBP1L1 FGFR3 PLXNA1 PLXNB1 FRAS1 FUT11 CELSR1 CSPG4 | 2.33e-05 | 243 | 229 | 12 | int:GGH |
| Interaction | CEP128 interactions | ZSWIM8 BCAS3 PDLIM7 STXBP4 CC2D1A NUP205 KIF14 CAMSAP1 FBF1 WASHC1 SORBS1 CEP164 CEP89 | 3.77e-05 | 297 | 229 | 13 | int:CEP128 |
| Cytoband | 4q35.2 | 5.31e-09 | 27 | 241 | 6 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 2.14e-07 | 117 | 241 | 8 | chr4q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 4.99e-05 | 316 | 241 | 9 | chr3p21 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 7.46e-07 | 3 | 165 | 3 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 7.46e-07 | 3 | 165 | 3 | 1189 | |
| GeneFamily | Signal transduction and activation of RNA metabolism family | 7.46e-07 | 3 | 165 | 3 | 1275 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.12e-05 | 16 | 165 | 4 | 14 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 2.12e-05 | 92 | 165 | 7 | 521 | |
| GeneFamily | Plexins | 6.02e-05 | 9 | 165 | 3 | 683 | |
| GeneFamily | PDZ domain containing | 7.82e-05 | 152 | 165 | 8 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.12e-04 | 160 | 165 | 8 | 555 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 4.91e-04 | 4 | 165 | 2 | 833 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.98e-04 | 161 | 165 | 7 | 593 | |
| GeneFamily | Fibrinogen C domain containing | 1.48e-03 | 25 | 165 | 3 | 554 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 1.69e-03 | 7 | 165 | 2 | 570 | |
| GeneFamily | MCM family | 2.86e-03 | 9 | 165 | 2 | 1085 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.63e-03 | 34 | 165 | 3 | 487 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 4.31e-03 | 11 | 165 | 2 | 1025 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | ZSWIM8 PDGFB ASH1L GPR135 KDM6B EHBP1L1 PTPRD RRP12 NR0B1 DUX4L5 DUX4L6 DUX4L4 DUX4L7 PLXNA1 CABP1 CRYBG2 DDX31 CILP DUX4 MLXIPL SNAPC4 TNS1 TNXB | 1.02e-05 | 909 | 238 | 23 | M41018 |
| Coexpression | PEREZ_TP53_TARGETS | DAB2IP NAAA KIF26A APC2 ASH1L BAP1 ITPKB FGF11 FGFR3 BRWD1 WHRN CRYBG2 TRIM2 DDX31 CILP GPR37 KIAA1549 CEP164 TRIM3 CELSR2 BEST4 CSPG4 RIMBP2 PROSER2 TNS1 MUC5AC VPS13B | 1.44e-05 | 1201 | 238 | 27 | M4391 |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP | RNF130 TTLL3 PDLIM7 DAG1 HSPA12B IFRD2 WDR13 BRWD1 RIMBP2 TNS1 | 1.57e-05 | 200 | 238 | 10 | M6988 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | ERBB3 SPINT1 SPTBN2 APC2 DAG1 NCL SMOC2 PCDH17 FGF11 CACNA1G PLXNB1 SEMA4F FRAS1 CUX2 SRSF1 DOCK10 CCDC88C SNED1 CELSR1 KHDRBS3 CELSR2 BAZ1A TNN CSPG4 MAST1 CNTN3 MADCAM1 | 5.37e-06 | 973 | 226 | 27 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | ERBB3 SPINT1 SPTBN2 APC2 SMOC2 PCDH17 FGF11 CACNA1G PLXNA1 PLXNB1 SEMA4F CRYBG2 CUX2 DOCK10 RASSF7 CCDC88C SNED1 MLXIPL CELSR1 CELSR2 BAZ1A TNN CSPG4 MAST1 CNTN3 RIMS2 MADCAM1 | 6.59e-06 | 984 | 226 | 27 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | cerebral cortex | SPTBN2 APC2 CSMD2 PCDH17 TTBK1 PTPRD SORCS2 PRRG3 CACNA1G NYAP1 WASF1 CABP1 CUX2 TRIM2 GPR37 KHDRBS2 C10orf90 KCNK12 GRIK4 ANO8 RASL10A CELSR3 KHDRBS3 CELSR2 GPR150 RELL2 MAST1 PRKAR1B SORCS3 CNTN3 RIMS1 FRMPD3 RIMS2 TNR | 8.44e-06 | 1428 | 226 | 34 | cerebral cortex |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | APC2 SMOC2 PCDH17 PTPRD FGF11 PRRG3 CACNA1G WHRN SEMA4F FRAS1 NPR2 CUX2 SRSF1 OLFML2B ARHGEF5 DOCK10 KIAA1549 GRIK4 RUNX2 SNED1 TNN CSPG4 MAST1 PRKAR1B CNTN3 MADCAM1 | 1.41e-05 | 967 | 226 | 26 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | SMOC2 GLI1 SORCS2 CACNA1G HSPG2 FRAS1 RHBDF1 ANPEP OLFML2B MLXIPL KHDRBS3 | 5.06e-09 | 187 | 235 | 11 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | ERBB3 SPINT1 DACT2 FGFR3 HSPG2 KHDRBS2 RASSF7 PPL ESYT3 MISP | 9.30e-08 | 195 | 235 | 10 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ERBB3 SPINT1 DACT2 SMOC2 PKHD1 KHDRBS2 RASSF7 PPL CELSR1 RIMBP2 | 9.76e-08 | 196 | 235 | 10 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPRD SGCE FGFR3 FRAS1 TRIM2 RUNX2 CELSR1 CNTN3 RIMS1 MUC5AC | 1.07e-07 | 198 | 235 | 10 | af399569c718f5fd971d73a7926768c9311002a3 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 PCDH17 PTPRD PTPRS SORCS2 PLXNB1 TRIM2 GPR37 C10orf90 CELSR2 | 1.12e-07 | 199 | 235 | 10 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 PCDH17 PTPRD PTPRS SORCS2 PLXNB1 TRIM2 GPR37 C10orf90 CELSR2 | 1.12e-07 | 199 | 235 | 10 | 6fb5f931e6217142de38c1fffc011e63bda4772b |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 PCDH17 PTPRD PTPRS SORCS2 PLXNB1 TRIM2 GPR37 C10orf90 CELSR2 | 1.12e-07 | 199 | 235 | 10 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 PCDH17 PTPRD PTPRS SORCS2 PLXNB1 TRIM2 GPR37 C10orf90 CELSR2 | 1.12e-07 | 199 | 235 | 10 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-07 | 181 | 235 | 9 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.14e-07 | 184 | 235 | 9 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-07 | 184 | 235 | 9 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.03e-07 | 187 | 235 | 9 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 188 | 235 | 9 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 188 | 235 | 9 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 188 | 235 | 9 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.35e-07 | 188 | 235 | 9 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 192 | 235 | 9 | f9777e0fdd86c2a514f05a42502888329a94b396 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 192 | 235 | 9 | 3a99c521c599a289ee2309d97be5ceb99f8aa220 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 192 | 235 | 9 | 562e15876088af9189744c9b2de5c4863d7f15fd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.97e-07 | 195 | 235 | 9 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.97e-07 | 195 | 235 | 9 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 196 | 235 | 9 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.08e-06 | 197 | 235 | 9 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.13e-06 | 198 | 235 | 9 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.13e-06 | 198 | 235 | 9 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-06 | 199 | 235 | 9 | 1621ce2968f3100e4c39e0ef8293232a5d76c614 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 200 | 235 | 9 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 200 | 235 | 9 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 1.67e-06 | 154 | 235 | 8 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 162 | 235 | 8 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-06 | 164 | 235 | 8 | ea02ca343b2b28e437304de889e2ae1e315a1197 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-06 | 176 | 235 | 8 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 4.83e-06 | 126 | 235 | 7 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 180 | 235 | 8 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 180 | 235 | 8 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.31e-06 | 180 | 235 | 8 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | e123ad8ee46a032825a0bd4b3586ddcb3eda03d4 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.49e-06 | 185 | 235 | 8 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.75e-06 | 186 | 235 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 186 | 235 | 8 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-06 | 187 | 235 | 8 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 187 | 235 | 8 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 7.30e-06 | 188 | 235 | 8 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 188 | 235 | 8 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.30e-06 | 188 | 235 | 8 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 189 | 235 | 8 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 7.59e-06 | 189 | 235 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 189 | 235 | 8 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 190 | 235 | 8 | d3e46cf800a07ca9b01c78192962d223b9785d05 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 190 | 235 | 8 | dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 190 | 235 | 8 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.89e-06 | 190 | 235 | 8 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 190 | 235 | 8 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 7.89e-06 | 190 | 235 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.89e-06 | 190 | 235 | 8 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 190 | 235 | 8 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.20e-06 | 191 | 235 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.20e-06 | 191 | 235 | 8 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-06 | 192 | 235 | 8 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.52e-06 | 192 | 235 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 193 | 235 | 8 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.85e-06 | 193 | 235 | 8 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.85e-06 | 193 | 235 | 8 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 193 | 235 | 8 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 193 | 235 | 8 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 194 | 235 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 194 | 235 | 8 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.18e-06 | 194 | 235 | 8 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.18e-06 | 194 | 235 | 8 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 194 | 235 | 8 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 194 | 235 | 8 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.53e-06 | 195 | 235 | 8 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.53e-06 | 195 | 235 | 8 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.53e-06 | 195 | 235 | 8 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.90e-06 | 196 | 235 | 8 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.90e-06 | 196 | 235 | 8 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 196 | 235 | 8 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.90e-06 | 196 | 235 | 8 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 197 | 235 | 8 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 197 | 235 | 8 | ec08a971e8dd9ad69359896c60ad77ff8af08fd0 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 197 | 235 | 8 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.03e-05 | 197 | 235 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.07e-05 | 198 | 235 | 8 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 198 | 235 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 198 | 235 | 8 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 198 | 235 | 8 | 84697f316d9195ebe838cf57f4dbdd9feea43bec | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 198 | 235 | 8 | eda85a592527992b51a00f288cff0c3239c47e6f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 198 | 235 | 8 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 199 | 235 | 8 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.11e-05 | 199 | 235 | 8 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 199 | 235 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 200 | 235 | 8 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-05 | 200 | 235 | 8 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 200 | 235 | 8 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 200 | 235 | 8 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 200 | 235 | 8 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.30e-05 | 160 | 235 | 7 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 160 | 235 | 7 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-05 | 161 | 235 | 7 | 2fe77af3b41e6eacb707a64feea18f9991618173 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 167 | 235 | 7 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; HL60; HT_HG-U133A | ERBB3 SPINT1 PDLIM7 CC2D1A PHF8 CISH TPP1 RRP12 CAMSAP1 MOK VHL KCNK12 VPS13B | 1.88e-07 | 198 | 239 | 13 | 3023_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | PDGFB DAG1 CC2D1A PLXND1 TAOK2 CISH PRRC2A PLXNA1 PLXNB1 DDX31 EFCAB2 FURIN | 1.31e-06 | 198 | 239 | 12 | 5335_DN |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | NAAA BCAS3 PDLIM7 SPTBN2 DAG1 PLXND1 CISH KMT2A MBD2 TRIM2 SIDT2 PRKAR1B | 1.38e-06 | 199 | 239 | 12 | 2115_UP |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | NAAA PDGFB GPR135 MCM4 CDC7 PTPRS C11orf68 OLFML2B ID1 SNAPC4 TNS1 | 5.66e-06 | 190 | 239 | 11 | 4452_DN |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | PDLIM7 ASH1L GPR135 NAA80 PLXND1 TAOK2 PLXNB1 VHL OLFML2B TRIM3 SIDT2 | 7.62e-06 | 196 | 239 | 11 | 7520_DN |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | PDLIM7 GCNT4 PCDH17 CISH PTPRS WHRN SEMA4F TRIM2 DOCK10 SIDT2 PRKAR1B | 7.99e-06 | 197 | 239 | 11 | 5060_UP |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | NAAA PDLIM7 ITPKB EHBP1L1 PLXNA1 HSPG2 NPR2 TRIM3 ZNF34 SIDT2 MLH3 | 8.80e-06 | 199 | 239 | 11 | 1475_DN |
| Drug | CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A | STARD13 PDLIM7 EHBP1L1 CAMSAP1 PLXNA1 NPR2 EFCAB2 FURIN PRKAR1B SNAPC4 MUC5AC | 9.22e-06 | 200 | 239 | 11 | 7082_UP |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | PDLIM7 GPR135 NAA80 C11orf68 PLXNB1 ID1 ID3 RASSF7 SNAPC4 TNS1 | 3.44e-05 | 190 | 239 | 10 | 4442_DN |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | PDLIM7 NAA80 ITPKB MBD2 BRWD1 NPR2 TRIM2 CELSR3 CELSR2 PRKAR1B | 3.60e-05 | 191 | 239 | 10 | 1227_UP |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | SPEG MCM4 TAS2R1 TPP1 KMT2A CACNA1G CAMSAP1 GP1BA SETD2 VPS13B | 3.60e-05 | 191 | 239 | 10 | 3861_UP |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | PDLIM7 TAOK2 CISH RRP12 PLXNB1 DDX31 RASSF7 SETD2 PRKAR1B SNAPC4 | 3.93e-05 | 193 | 239 | 10 | 7409_DN |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | BCAS3 PDLIM7 SEMA4F CRYBG2 TRIM2 KCNK12 SORBS1 CEP164 SNAPC4 MUC5AC | 4.10e-05 | 194 | 239 | 10 | 7529_DN |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; PC3; HT_HG-U133A | PDGFB GPR135 NAA80 CC2D1A CACNA1G CAMSAP1 NPR2 KCNK12 CEP164 SNAPC4 | 4.10e-05 | 194 | 239 | 10 | 4575_UP |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A | PDGFB ITPKB TAOK2 FGFR3 HSPG2 CEP164 TRIM3 PRKAR1B SNAPC4 RIMS2 | 4.10e-05 | 194 | 239 | 10 | 6070_DN |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | ZSWIM8 DAG1 TAOK2 EHBP1L1 RRP12 PLXNB1 HSPG2 RASSF7 PRKAR1B CBX8 | 4.29e-05 | 195 | 239 | 10 | 4360_DN |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | STARD13 PDE3B PDGFB ITPKB SGCE FGFR3 RHBDF1 MLH3 CELSR2 SNAPC4 | 4.29e-05 | 195 | 239 | 10 | 5591_DN |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 4.29e-05 | 195 | 239 | 10 | 3755_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | NAAA PIEZO1 PHF8 ECSIT C11orf68 CAMSAP1 PRRC2A BRWD1 CCDC88C KHDRBS1 | 4.48e-05 | 196 | 239 | 10 | 1178_DN |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | STARD13 ASH1L CISH FGFR3 GOLGA1 TRIM2 GPR37 CCDC88C MLH3 PRKAR1B | 4.48e-05 | 196 | 239 | 10 | 6988_DN |
| Drug | (+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 4.67e-05 | 197 | 239 | 10 | 161_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 4.67e-05 | 197 | 239 | 10 | 6663_DN | |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; PC3; HT_HG-U133A | PDGFB CISH DDX31 DOCK10 SORBS1 SIDT2 CELSR3 PRKAR1B RIMS2 TNS1 | 4.67e-05 | 197 | 239 | 10 | 7046_UP |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | PDE3B DAG1 NAA80 TAOK2 PTPRS PLXNB1 MOK TRIM2 EFCAB2 PRKAR1B | 4.88e-05 | 198 | 239 | 10 | 5393_DN |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A | PCDH17 TAS2R1 PTPRD RRP12 NR0B1 CAMSAP1 CRYBG2 MLXIPL RIMS2 TNS1 | 4.88e-05 | 198 | 239 | 10 | 4071_UP |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | PDGFB DAG1 PRR14 PRRC2A PLXNB1 WHRN GPR37 ZNF34 CELSR2 FURIN | 4.88e-05 | 198 | 239 | 10 | 4592_DN |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 4.88e-05 | 198 | 239 | 10 | 3790_UP | |
| Drug | SC-560; Down 200; 10uM; PC3; HT_HG-U133A | PDGFB PDLIM7 SPTBN2 KDM6B NPR2 ACOT8 CCDC88C CELSR3 CELSR2 CSPG4 | 4.88e-05 | 198 | 239 | 10 | 6865_DN |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | STARD13 SPINT1 PHF8 PCDH17 CAMSAP1 PLXNA1 VHL CABP1 CRYBG2 TRIM3 | 5.31e-05 | 200 | 239 | 10 | 2919_UP |
| Drug | Cgp77675 | 8.50e-05 | 43 | 239 | 5 | CID005311381 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 179 | 239 | 9 | 3887_UP | |
| Drug | KM2210 | 1.30e-04 | 10 | 239 | 3 | CID000053181 | |
| Drug | H 661 | 1.30e-04 | 10 | 239 | 3 | CID003056529 | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.42e-04 | 183 | 239 | 9 | 7088_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.54e-04 | 185 | 239 | 9 | 4327_DN | |
| Drug | Methamphetamine | BCL9L ABL1 GBF1 PDGFB PDLIM7 SPEG KDM6B HSPA12B TAOK2 FAH TAS2R1 EHBP1L1 PTPRS GLI1 FGFR3 BRWD1 HSPG2 RHBDF1 PUSL1 ID1 ID3 SORBS1 PLEKHG2 SIDT2 GPR150 EIF4EBP1 SORCS3 RIMS2 TNS1 CBX8 | 1.65e-04 | 1401 | 239 | 30 | ctd:D008694 |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 1.74e-04 | 188 | 239 | 9 | 4456_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.74e-04 | 188 | 239 | 9 | 6195_DN | |
| Drug | BO-1 | 1.77e-04 | 11 | 239 | 3 | CID016122563 | |
| Drug | P-choline | 1.77e-04 | 11 | 239 | 3 | CID000124441 | |
| Drug | A-35 | 1.77e-04 | 11 | 239 | 3 | CID000120563 | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 1.89e-04 | 190 | 239 | 9 | 7070_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HG-U133A | 2.04e-04 | 192 | 239 | 9 | 611_DN | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.04e-04 | 192 | 239 | 9 | 1829_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.12e-04 | 193 | 239 | 9 | 4431_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.12e-04 | 193 | 239 | 9 | 5215_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 3321_DN | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 5630_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 1707_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 4246_DN | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 4275_DN | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 4260_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 4492_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 3812_UP | |
| Drug | 17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 1213_UP | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.20e-04 | 194 | 239 | 9 | 7196_DN | |
| Drug | 5666823; Down 200; 100uM; MCF7; HG-U133A | 2.29e-04 | 195 | 239 | 9 | 609_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.29e-04 | 195 | 239 | 9 | 5329_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.29e-04 | 195 | 239 | 9 | 3941_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.29e-04 | 195 | 239 | 9 | 6330_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.29e-04 | 195 | 239 | 9 | 2761_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.29e-04 | 195 | 239 | 9 | 5228_DN | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A | SPINT1 PDLIM7 NAA80 PLXND1 EHBP1L1 PRRC2A DDX31 DOCK10 FURIN | 2.29e-04 | 195 | 239 | 9 | 1290_DN |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.29e-04 | 195 | 239 | 9 | 4557_UP | |
| Drug | fullerene C60 | ABL1 PDGFB KIF26A BCAS3 PIEZO1 APC2 ASH1L DACT2 MCM2 KDM6B MBD6 HSPA12B PCDH17 EHBP1L1 CACNA1G SLC35E4 PRRC2A WHRN EGLN2 AMN COA3 ANPEP PLEKHG2 RUNX2 CEP164 PPL CEP89 RELL2 OTOP1 PRKAR1B TNS1 | 2.33e-04 | 1498 | 239 | 31 | ctd:C069837 |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 4063_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 5833_DN | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | GPR135 TAOK2 TAS2R1 PTPRS NR0B1 CACNA1G GP1BA KHDRBS2 PRKAR1B | 2.38e-04 | 196 | 239 | 9 | 6601_UP |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A | PDLIM7 SPTBN2 PLXND1 TAOK2 C11orf68 WHRN DOCK10 FNDC4 SNAPC4 | 2.38e-04 | 196 | 239 | 9 | 7316_UP |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 4739_DN | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 6605_DN | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 6884_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 3121_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 5069_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; HL60; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 2533_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 3783_DN | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; PC3; HT_HG-U133A | 2.38e-04 | 196 | 239 | 9 | 4473_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 7130_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 2117_UP | |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; HL60; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 2412_DN | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 6055_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 2327_DN | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 3529_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 3525_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 3781_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 5411_UP | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 3250_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.47e-04 | 197 | 239 | 9 | 3632_UP | |
| Drug | gentamicin | 2.56e-04 | 198 | 239 | 9 | CID000003467 | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 4447_DN | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 2083_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 3723_UP | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A | 2.56e-04 | 198 | 239 | 9 | 1761_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 4078_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 2228_UP | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 3324_UP | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 7501_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 4432_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 6016_DN | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 239 | 9 | 5522_UP | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 1.72e-06 | 4 | 224 | 3 | DOID:0090131 (is_implicated_in) | |
| Disease | level of plexin-D1 in blood serum | 5.74e-05 | 2 | 224 | 2 | OBA_2042940 | |
| Disease | thanatophoric dysplasia (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:13481 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 7.87e-05 | 93 | 224 | 6 | C1535926 | |
| Disease | Malignant neoplasm of prostate | DAB2IP RNF130 ERBB3 ABO ERF ASH1L DAG1 BAP1 TPP1 KMT2A MBD2 ARHGEF5 ID3 PPL SETD2 | 8.14e-05 | 616 | 224 | 15 | C0376358 |
| Disease | Prostatic Neoplasms | DAB2IP RNF130 ERBB3 ABO ERF ASH1L DAG1 BAP1 TPP1 KMT2A MBD2 ARHGEF5 ID3 PPL SETD2 | 8.14e-05 | 616 | 224 | 15 | C0033578 |
| Disease | cortical thickness | ERBB3 ABO SPTBN2 LAMA1 PLXND1 SMOC2 MBD6 PCDH17 PKD1 PKHD1 KMT2A FGFR3 HSPG2 NPR2 RUNX2 POLR1D CELSR1 BAZ1A FURIN TNS1 CBX8 | 1.27e-04 | 1113 | 224 | 21 | EFO_0004840 |
| Disease | CD209 antigen measurement | 1.48e-04 | 14 | 224 | 3 | EFO_0008077 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 1.71e-04 | 3 | 224 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 1.71e-04 | 3 | 224 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | breast cancer, ovarian carcinoma | 1.75e-04 | 37 | 224 | 4 | EFO_0001075, MONDO_0007254 | |
| Disease | asialoglycoprotein receptor 1 measurement | 3.41e-04 | 4 | 224 | 2 | EFO_0020164 | |
| Disease | Sotos' syndrome | 3.41e-04 | 4 | 224 | 2 | C0175695 | |
| Disease | response to angiotensin-converting enzyme inhibitor, cardiovascular event measurement, response to angiotensin receptor blocker | 3.41e-04 | 4 | 224 | 2 | EFO_0005325, EFO_0006919, EFO_0010735 | |
| Disease | velopharyngeal dysfunction | 3.48e-04 | 122 | 224 | 6 | EFO_0009336 | |
| Disease | red blood cell density measurement | STARD13 ABO PDGFB BCAS3 STXBP4 PIEZO1 MCM4 KDM6B NUP205 SORCS2 PKHD1 MBD2 EGLN2 SORBS1 BAZ1A PRKAR1B VPS13B | 4.32e-04 | 880 | 224 | 17 | EFO_0007978 |
| Disease | muscular dystrophy (implicated_via_orthology) | 5.19e-04 | 21 | 224 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.24e-04 | 49 | 224 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | ABO BCAS3 ADSS2 PKHD1 KMT2A BOD1L1 ANPEP GRIK4 RUNX2 CSPG4 TNS1 TNXB | 5.58e-04 | 509 | 224 | 12 | EFO_0004695 |
| Disease | Renal carcinoma | 5.65e-04 | 5 | 224 | 2 | C1378703 | |
| Disease | relapsing-remitting multiple sclerosis (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:2378 (is_implicated_in) | |
| Disease | breast cancer, COVID-19 | 5.98e-04 | 22 | 224 | 3 | MONDO_0007254, MONDO_0100096 | |
| Disease | e-selectin measurement | 5.98e-04 | 22 | 224 | 3 | EFO_0004575 | |
| Disease | Intellectual Disability | APC2 LAMA1 ASH1L KDM6B TPP1 TSEN34 CACNA1G WASF1 CUX2 SETD2 POLR3B | 6.65e-04 | 447 | 224 | 11 | C3714756 |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 6.83e-04 | 23 | 224 | 3 | C1708353 | |
| Disease | Bladder Neoplasm | 7.21e-04 | 140 | 224 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 7.49e-04 | 141 | 224 | 6 | C0005684 | |
| Disease | achondroplasia (implicated_via_orthology) | 8.43e-04 | 6 | 224 | 2 | DOID:4480 (implicated_via_orthology) | |
| Disease | protein CASC4 measurement | 8.43e-04 | 6 | 224 | 2 | EFO_0802927 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 9.86e-04 | 26 | 224 | 3 | EFO_0010366 | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 1.10e-03 | 27 | 224 | 3 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 1.10e-03 | 27 | 224 | 3 | EFO_0004629, EFO_0004630 | |
| Disease | hereditary lymphedema (is_implicated_in) | 1.17e-03 | 7 | 224 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | Craniosynostosis syndrome | 1.17e-03 | 7 | 224 | 2 | cv:C0010278 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.20e-03 | 61 | 224 | 4 | C1961102 | |
| Disease | intelligence, response to cranial radiation therapy | 1.23e-03 | 28 | 224 | 3 | EFO_0004337, EFO_0010950 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.36e-03 | 63 | 224 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | gallstones | 1.43e-03 | 108 | 224 | 5 | EFO_0004210 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 1.56e-03 | 8 | 224 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | X-linked Adrenal Hypoplasia | 1.56e-03 | 8 | 224 | 2 | C0342482 | |
| Disease | stanniocalcin-1 measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0020753 | |
| Disease | waist circumference, sexual dimorphism | 1.56e-03 | 8 | 224 | 2 | EFO_0004342, EFO_0005951 | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin concentration | 1.56e-03 | 8 | 224 | 2 | EFO_0004509, EFO_0004528 | |
| Disease | age at initiation of corrective lens use | 1.56e-03 | 8 | 224 | 2 | EFO_0021781 | |
| Disease | factor VIII measurement, coronary artery disease | 1.74e-03 | 113 | 224 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | Liver carcinoma | PDGFB RPS6KA3 MCM2 GLI1 KIF14 KMT2A OLFML2B MLXIPL CELSR3 CSPG4 PITPNM3 | 1.82e-03 | 507 | 224 | 11 | C2239176 |
| Disease | manic episode measurement, depressive episode measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0007704, EFO_0007705 | |
| Disease | triglyceride change measurement, response to exercise | 1.99e-03 | 9 | 224 | 2 | EFO_0007681, EFO_0007768 | |
| Disease | platelet component distribution width | ABO SMOC2 NYAP1 PRRC2A PIF1 GP1BA BRWD1 DOCK10 MLXIPL SETD2 SIDT2 METTL24 TNN TNXB | 2.01e-03 | 755 | 224 | 14 | EFO_0007984 |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.11e-03 | 118 | 224 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.11e-03 | 71 | 224 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | Spinocerebellar Ataxia Type 2 | 2.17e-03 | 34 | 224 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.17e-03 | 34 | 224 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.17e-03 | 34 | 224 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.17e-03 | 34 | 224 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.17e-03 | 34 | 224 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.17e-03 | 34 | 224 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.36e-03 | 35 | 224 | 3 | C0752122 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 2.43e-03 | 239 | 224 | 7 | EFO_0010934 | |
| Disease | Burkitt Lymphoma | 2.56e-03 | 36 | 224 | 3 | C0006413 | |
| Disease | Corneal astigmatism | 2.84e-03 | 77 | 224 | 4 | EFO_1002040 | |
| Disease | Disproportionate short stature | 2.84e-03 | 77 | 224 | 4 | C0878659 | |
| Disease | hepatocyte growth factor-like protein measurement | 2.99e-03 | 38 | 224 | 3 | EFO_0008154 | |
| Disease | Malignant Neoplasms | 3.00e-03 | 128 | 224 | 5 | C0006826 | |
| Disease | Kidney Neoplasm | 3.47e-03 | 40 | 224 | 3 | C0022665 | |
| Disease | craniosynostosis (is_implicated_in) | 3.60e-03 | 12 | 224 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | Oligospermia | 3.60e-03 | 12 | 224 | 2 | C0028960 | |
| Disease | Malignant neoplasm of breast | ERBB3 ABL1 PDLIM7 STXBP4 RPS6KA3 APC2 BAP1 PTPRD GLI1 BOD1L1 PRRC2A PLXNB1 SRSF1 SORBS1 SETD2 TNS1 VPS13B | 3.61e-03 | 1074 | 224 | 17 | C0006142 |
| Disease | Congenital small ears | 3.72e-03 | 41 | 224 | 3 | C0152423 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 4.24e-03 | 13 | 224 | 2 | C0238288 | |
| Disease | Paraganglioma | 4.24e-03 | 13 | 224 | 2 | C0030421 | |
| Disease | Profound Mental Retardation | 4.26e-03 | 139 | 224 | 5 | C0020796 | |
| Disease | Mental deficiency | 4.26e-03 | 139 | 224 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.26e-03 | 139 | 224 | 5 | C0025363 | |
| Disease | free cholesterol to total lipids in IDL percentage | 4.26e-03 | 43 | 224 | 3 | EFO_0022278 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 4.26e-03 | 43 | 224 | 3 | EFO_0022290 | |
| Disease | metabolic syndrome | 4.36e-03 | 200 | 224 | 6 | EFO_0000195 | |
| Disease | serum gamma-glutamyl transferase measurement | ABO RPS6KA3 ASH1L HSPA12B PKD1 PKHD1 KMT2A PRRC2A CABP1 CUX2 AMN MLXIPL SETD2 CELSR2 STKLD1 | 4.43e-03 | 914 | 224 | 15 | EFO_0004532 |
| Disease | granulocyte percentage of myeloid white cells | 4.55e-03 | 268 | 224 | 7 | EFO_0007997 | |
| Disease | stomach cancer (is_marker_for) | 4.66e-03 | 142 | 224 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Liver neoplasms | 4.66e-03 | 142 | 224 | 5 | C0023903 | |
| Disease | Malignant neoplasm of liver | 4.66e-03 | 142 | 224 | 5 | C0345904 | |
| Disease | Malignant neoplasm of kidney | 4.84e-03 | 45 | 224 | 3 | C0740457 | |
| Disease | Gastric Adenocarcinoma | 4.84e-03 | 45 | 224 | 3 | C0278701 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 4.84e-03 | 45 | 224 | 3 | EFO_0022236 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 4.92e-03 | 14 | 224 | 2 | DOID:7474 (is_marker_for) | |
| Disease | osteoarthritis, hip | 5.37e-03 | 92 | 224 | 4 | EFO_1000786 | |
| Disease | free cholesterol in medium VLDL measurement | 5.47e-03 | 47 | 224 | 3 | EFO_0022269 | |
| Disease | Benign neoplasm of bladder | 5.64e-03 | 15 | 224 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.64e-03 | 15 | 224 | 2 | C0154091 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.64e-03 | 15 | 224 | 2 | C0496930 | |
| Disease | triacylglycerol 52:3 measurement | 5.64e-03 | 15 | 224 | 2 | EFO_0010415 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 5.64e-03 | 15 | 224 | 2 | EFO_0010367 | |
| Disease | Disorder of eye | 5.77e-03 | 212 | 224 | 6 | C0015397 | |
| Disease | total lipids in lipoprotein particles measurement | 5.81e-03 | 48 | 224 | 3 | EFO_0022309 | |
| Disease | monocyte count | C3orf22 ABO ERF BCAS3 PIEZO1 SPTBN2 ASH1L RRP12 PKD1 NYAP1 CRYBG2 DOCK10 RUNX2 MLXIPL SETD2 UBXN11 BAZ1A MAST1 CBX8 | 5.90e-03 | 1320 | 224 | 19 | EFO_0005091 |
| Disease | overall survival, pancreatic carcinoma | 6.15e-03 | 49 | 224 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 6.15e-03 | 49 | 224 | 3 | EFO_0022256 | |
| Disease | platelet crit | STARD13 ABO PDGFB KIF26A BCAS3 STXBP4 PIEZO1 DAG1 KDM6B NUP205 CDC7 PIF1 GP1BA DOCK10 CBX8 | 6.37e-03 | 952 | 224 | 15 | EFO_0007985 |
| Disease | migraine disorder, fasting blood insulin measurement | 6.42e-03 | 16 | 224 | 2 | EFO_0004466, MONDO_0005277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRASRLALQGPPGTI | 196 | Q6ZR03 | |
| PSPAISLRNFGRVRG | 421 | Q8NFU0 | |
| DTLPVPSGQRRGRVP | 6 | Q4AC99 | |
| RGDPPGDLRSVLVTT | 16 | O14734 | |
| AGGPLTPRRVSSDLQ | 521 | P50548 | |
| LSLPVGTLNRPRGSQ | 1031 | P21860 | |
| GAQRTPGPELRLSSQ | 16 | A0FGR9 | |
| SQPVSETGVRPREGL | 26 | Q8IZF5 | |
| VNGVPSRSPRLVASG | 1696 | Q9NR48 | |
| VPREPLRRVAVTGGT | 6 | Q96HD9 | |
| PAAVPRVTLGTGRQL | 156 | P16442 | |
| RQLTGSRLPAPISAG | 991 | Q7Z408 | |
| GPQQTAPRLGVFTRS | 2241 | Q7Z408 | |
| RVPRARTEPGGSQLV | 2096 | Q6UVK1 | |
| PPEGRRKRTAVTGSQ | 91 | P0CJ87 | |
| SRQGLRRPSILPEGS | 1036 | Q12774 | |
| PATRRVVLGDGVQLP | 16 | Q13541 | |
| DLAAGVGRSRVPVRP | 376 | Q92560 | |
| PRTQRTPGRSPAAAI | 501 | Q96C12 | |
| PGASPVRVRSISALG | 156 | Q9BXJ7 | |
| RVVLRGVGGSQPPDI | 136 | P15144 | |
| GVRPPGARNLTLAVV | 16 | P20594 | |
| QGPRPLLAVERTGQR | 6 | Q9NSE2 | |
| GPLLRPAGRRTTPQT | 2296 | Q9NYQ6 | |
| EIDPRSGVIRTRGPV | 341 | Q9HCU4 | |
| TLRVRAQDGGRPPLS | 471 | Q9HCU4 | |
| PPEGRRKRTAVTGSQ | 91 | P0CJ89 | |
| RQRGSITPRIRTPET | 631 | O14529 | |
| RRPSRCTGGVVVRPQ | 11 | Q9H6U6 | |
| RLVPTRSIPVRGLGA | 61 | Q8N5N4 | |
| PREEGARGSQRVLPQ | 126 | Q9NZU7 | |
| RSIVSRRPSEGPQPL | 621 | Q5T5Y3 | |
| QGPTDAQRAVRIRPG | 101 | Q8WU49 | |
| PVPRDSGLRAGLIIT | 986 | Q9P241 | |
| LRPNRRLVVPGSSVE | 121 | Q8WXS8 | |
| PSPVTLGRRSSGRQG | 1416 | Q9NRL2 | |
| LGAVASLPDRGRPTV | 106 | Q8N7S6 | |
| GTALAPVGAPALRTR | 1111 | Q9HCE9 | |
| GQETVAPRLSRGPLR | 336 | Q96M43 | |
| QFVLRRTGPSLAGRP | 81 | Q02833 | |
| SGSTVNQPIPRRVTG | 186 | O95199 | |
| IRSVSGSLPEGVPRV | 681 | O14917 | |
| SREDGRPVPSGTQQR | 1711 | P98160 | |
| SLRVNGGRPVLRSSP | 4026 | P98160 | |
| GRGVDLTEPTQPTRN | 196 | P20339 | |
| VTVQEPGRGAPLTFR | 41 | Q86XS8 | |
| GRTGPVAVRESPQLA | 1046 | Q92621 | |
| FRTSEGIVPTPGRNL | 236 | Q9HCM3 | |
| QRRRGNDPLTSSPGR | 16 | P49736 | |
| GLATVRRAGQTPTTP | 796 | Q5VWQ8 | |
| STPVLLTRGGAPERQ | 901 | Q8N612 | |
| GTPRSGVRGTPVRQR | 101 | P33991 | |
| VSEGPQPGLRRALSS | 381 | Q8IVT2 | |
| AEQAGTPRPRLSLGI | 76 | Q5VUJ9 | |
| TPRPRLSLGISQATG | 81 | Q5VUJ9 | |
| TVFRLLEGRGPQTPR | 371 | Q96DN6 | |
| RGLPVRAPLSTLNGE | 121 | P41134 | |
| TPNPVGRLALQRRTT | 81 | Q15058 | |
| IGPDTISGPRVQRSL | 3826 | Q86XX4 | |
| GSTRTRRPEISQAGP | 286 | Q13477 | |
| PPEGRRKRTAVTGSQ | 91 | Q9UBX2 | |
| AQRPGGATRIPRSVS | 16 | Q92805 | |
| GEPVQGLVFTSRRLP | 191 | Q93015 | |
| GGTSPREGVVITRNR | 251 | Q02083 | |
| RPQTIGAASRIPGVT | 661 | Q9Y2Z2 | |
| HANRVRVGSTPLGRP | 51 | O76014 | |
| PVLEPVGRSTLAQRR | 716 | P51812 | |
| HANRVRVGSTPLGRP | 51 | O76015 | |
| TDPRNPITVIRGLAG | 1206 | O15054 | |
| RTRGAIIQTPTLGPI | 371 | Q14118 | |
| LPREASTPGRNALGR | 1616 | Q9P219 | |
| PPEGRRKRTAVTGSQ | 91 | P0CJ86 | |
| GGRRNTTPSVPSLRG | 41 | Q969W3 | |
| VDRSGQRIPVSGRVG | 76 | Q6P4F2 | |
| ARPVTRSPGGSQEQR | 186 | P01127 | |
| PETGPRQGGTRLTIT | 871 | Q9UIW2 | |
| PSQGLGRRRRVVPET | 1296 | O43157 | |
| PRRSPVSGGRTITVA | 1076 | Q9Y4D7 | |
| GAPLARRNAITPGSR | 326 | Q9HB15 | |
| VRPGPTRAQETFGNR | 631 | Q9UHC1 | |
| ALPGSGTTPLLRTRV | 576 | O60437 | |
| PQLRRSSGTSGLLPV | 436 | Q13370 | |
| VRLRRPSVNGEPGSV | 1251 | Q8N3D4 | |
| ARIPPLRRGATTLGV | 1301 | Q9ULI4 | |
| GTTVSRRVGPPVSLE | 526 | P08151 | |
| VLGSGTNGRVPVLRP | 371 | Q9UQ07 | |
| GVPLRGATVFPSLRT | 51 | P98088 | |
| SVNSRPNVILPGREG | 16 | Q9H8H2 | |
| LFGQAPGVVRVRRSP | 526 | Q96MM6 | |
| PGVVRVRRSPLTYGV | 531 | Q96MM6 | |
| RPRPGTGQSRSFRIL | 156 | Q9NR12 | |
| PVEGLGAPRQVAVRR | 1316 | Q9Y2H9 | |
| RAIRLELQGPRGSPN | 551 | P19338 | |
| GSTLPRRGTRNAIVP | 971 | Q86Y26 | |
| SAGAVLRIQPLRTPR | 86 | Q13332 | |
| RRGRQLPQVPVRSGS | 1266 | Q86UR5 | |
| REPGGSRPVSAQRRV | 16 | Q92914 | |
| LTTRRRETGGNEPLP | 321 | P51843 | |
| RNGSVPVEIVPRSAR | 561 | Q9H158 | |
| STPVAGRRGRQLPQL | 1151 | Q9UQ26 | |
| RPGPTVRAGENVTLS | 131 | Q99706 | |
| RRLTPEQPRIGASAG | 136 | I0J062 | |
| PQPIRLSGVDSVFGR | 91 | Q96PS1 | |
| LAPSPVSGVRREGAR | 41 | Q9UBB5 | |
| SPAPRRGGVRASVPQ | 41 | Q7RTM1 | |
| REVSPPGARTRGQQR | 3026 | Q8NFC6 | |
| LQGQALARTPPTRRG | 811 | O95996 | |
| RQIGDQEGPRPARST | 226 | Q8TES7 | |
| PSQGPGLQARSRSRL | 416 | Q8IZ08 | |
| QSGGRLRRPVNVPLD | 101 | P17658 | |
| PEQRGVLGTSRTRPR | 321 | Q6TDP4 | |
| EPGGPRRGNSTNRRV | 231 | O15354 | |
| AQGGRPSLIARIPVA | 326 | Q9HC52 | |
| RRESPIEGQRSETGP | 411 | Q6ZUS6 | |
| GPLARGRPSLVRQDA | 641 | Q5SW24 | |
| ISPEGPLQGRRSTEL | 291 | Q96BY6 | |
| RAAGVRVGLLSSPAP | 456 | O43497 | |
| TLIRVPGIPGEISRS | 341 | Q9P109 | |
| RRQQVAPRAGTPGFR | 366 | O00311 | |
| LTGRTVAIPQPRQRS | 61 | Q96ST8 | |
| SERPVVVRSVRPGGP | 71 | Q5JV73 | |
| VFRPPSALGAVGVTR | 46 | Q495W5 | |
| VQVRSIGLRGESPPG | 116 | Q9H6D8 | |
| VRIPGGPAVANSVAR | 36 | P09958 | |
| PPEGRRKRTAVTGSQ | 91 | Q6RFH8 | |
| VTVRPVSSGEALPRG | 196 | Q8N1P7 | |
| PNRGLGRRPSDLTIS | 906 | Q86UU0 | |
| VQRPGPGLSQEAARR | 561 | Q6P1N0 | |
| RSDQVTRGTVTPPPR | 771 | P00519 | |
| PRRRTRNIVTGLGIG | 51 | Q9Y2R0 | |
| PPEGRRKRTAVTGSQ | 91 | P0CJ90 | |
| TIPRGLSNGEETPRR | 676 | Q9NSI6 | |
| PLVAGRRPSALSQGR | 621 | P07359 | |
| AQRTGRRLVGLEPTP | 36 | Q12894 | |
| RRLVGLEPTPTGSLT | 41 | Q12894 | |
| RGATPEGIFLRVPTA | 906 | Q92538 | |
| GAITRGATVTRGVPP | 321 | Q07666 | |
| GAPAPRARTAGIQRI | 341 | Q07666 | |
| LTPRGSTVTRGALPV | 221 | Q5VWX1 | |
| LNRPRAATVVARGPL | 331 | P31321 | |
| TLRTRGVPAPAITRG | 191 | O75525 | |
| RGGVTARPVGVVVPR | 206 | O75525 | |
| SPVLGARGPRLEVVA | 266 | Q6UWL6 | |
| GVQIVRRRGRPPSTE | 296 | Q03164 | |
| LRELVPGVPRGTQLS | 51 | Q02535 | |
| VFSTRGDPRPRIGVA | 21 | P16930 | |
| SQRAIPPRSIRGDQI | 226 | Q96KS0 | |
| RTRVLIGDPGRPQFS | 211 | Q8IXQ9 | |
| PLVRIARLSSGEGPT | 436 | P22607 | |
| RPEVSSCGRTGPLQR | 136 | Q9NYQ7 | |
| PPEGRRKRTAVTGSQ | 91 | P0CJ88 | |
| PEERRPRGTATLSNG | 876 | Q16099 | |
| QLREAGGTRIPRPAL | 221 | P0C7U9 | |
| RVLGSPTPLVLRSDG | 206 | Q9P232 | |
| TGTSISQVPRRLPRG | 26 | Q9BQ95 | |
| RSATRVAGGPVTPRK | 11 | P18545 | |
| GPRGSSTVTIPRERL | 2316 | P98161 | |
| DGSGSVLRIQPLRTP | 76 | P23468 | |
| TQVHGLRRSLGPRAP | 106 | Q96MR7 | |
| GVPLQSNRLGPTSRL | 16 | A6NHM9 | |
| ASRTPGDGVSRLPVL | 346 | Q6ZVC0 | |
| RQVTYVRSGRRAPPG | 71 | Q5JXM2 | |
| TRGTLPAVEPFQRGL | 86 | P0DPB6 | |
| PVRTLRRVSVSPGQA | 191 | Q8N0Z8 | |
| GTGLPAITDVPRRIS | 326 | Q13950 | |
| ALRQRIAETRPAGAP | 106 | Q92737 | |
| VAVEELSPGGQPRRR | 21 | Q9H611 | |
| RTPSVRPGQDVRLQA | 16 | Q3SY00 | |
| RPGQDVRLQAPGTRT | 21 | Q3SY00 | |
| SGVLPQRPRRGSISE | 231 | Q3SY00 | |
| PRGSAGPQRSRPVTV | 806 | O15034 | |
| PVQNGGLRDSSLTPR | 236 | Q8NC24 | |
| ISLGREQVPGAREPR | 431 | Q9Y3M8 | |
| QGRSFEPVGTRPRVD | 386 | Q8NBJ9 | |
| SQGRFPRSVGQPSRR | 1066 | Q7Z5M5 | |
| NEVRPAGTPIGALRI | 706 | A6NHR9 | |
| AVLSGPVSGRVPRSV | 26 | O95754 | |
| RPGRFDREVVIGTPT | 356 | Q9BVQ7 | |
| GQETVAPRLSRGPLR | 336 | Q5VWK0 | |
| GGARRSRRAQPPITQ | 126 | Q9UPU3 | |
| RRADSLPRPQGITVQ | 396 | Q86WR7 | |
| PRTGVRRGTGVLVEF | 1016 | O94761 | |
| RSSSQPPGRVLVQGA | 181 | P27987 | |
| PPGRVLVQGARSEER | 186 | P27987 | |
| VGGLPRSRVVRRGVT | 2436 | P25391 | |
| ASGPPSRRVRLVFLG | 36 | Q8NGU9 | |
| RGVRAAGGRTVPPNV | 536 | Q9BWN1 | |
| GLAVSRQAVRSPGPL | 21 | Q8IYU8 | |
| STAGPRRGQRIAVPV | 346 | Q96CC6 | |
| GRLGPHAQLTRVPRS | 56 | Q96PQ0 | |
| ERSQRTDRGTEPGPI | 1736 | P48634 | |
| RQPLPGTLAGRRSRT | 1211 | Q9UL54 | |
| EGGANTRQPLPRIVT | 831 | Q9P202 | |
| TRQPLPRIVTIQRGG | 836 | Q9P202 | |
| PPTVLRVLRGHTRGV | 206 | Q9H1Z4 | |
| VTTQRRQRTSPPLGG | 776 | P08F94 | |
| RRTVTLRRQPVGGLG | 71 | Q9NY99 | |
| PRARPGGNRVTVVLG | 21 | P30520 | |
| RRLSGQPSAGLVPIT | 91 | Q9H3Y6 | |
| RGRPASQPTVIRGIT | 286 | Q68BL8 | |
| QTSLTPLGRNGRSIP | 461 | Q6ZWJ1 | |
| SLPRRRDQEGSVGPS | 61 | Q9NP71 | |
| ITSALDRGGRVPLPI | 201 | O43556 | |
| AQRVLATQPGPGRGR | 1126 | Q5JTH9 | |
| TQPPRFSELVDGRGR | 1241 | Q8TER0 | |
| RGLVDTPPSALRGSQ | 151 | Q9UPV0 | |
| PAAGTVQGRVPSRRQ | 1141 | O75339 | |
| GFASITITARRVGPP | 136 | Q96M02 | |
| TSGRPITPGTLRQLA | 146 | Q9H3H3 | |
| LGPRQAVRPSVRAES | 51 | Q6IPW1 | |
| RVPGRGAPISALLSI | 216 | Q9NYW7 | |
| RARPGAGISSLQTVP | 421 | Q2L4Q9 | |
| TTGDVRPPRNVAGFR | 186 | Q5TCY1 | |
| NGPRGERQTRTRGPA | 2176 | O15020 | |
| RRLPGSPRQAQATGA | 206 | Q15772 | |
| PRNLRPSAVTQSGGI | 976 | Q9UQP3 | |
| GLRTAFVPTALRRGP | 191 | Q5K4L6 | |
| RTVGALPRGPRQNSR | 31 | Q9BSV6 | |
| SNRRRPTQGERGPGS | 6 | Q8NE28 | |
| VLVDTGRPIPGTSTR | 261 | Q9H3U7 | |
| GLRREIPIPSTGSVE | 451 | O43278 | |
| IFTGAQDPGLQRRPR | 106 | Q6VEQ5 | |
| LTVGVPGRRSLALTP | 991 | Q9BX66 | |
| ATVRGLRGPNLTSPA | 3911 | P22105 | |
| PAPVRGGSSREAVQR | 631 | Q9HBL0 | |
| IFTGAQDPGLQRRPR | 106 | A8K0Z3 | |
| IGVDRPPRTAQGLRT | 56 | O95073 | |
| VPRGIGPTTRATLTD | 641 | Q92752 | |
| AGRPRPVLRSVNSRE | 56 | P40337 | |
| IFTGAQDPGLQRRPR | 106 | C4AMC7 | |
| GPRAVLTRQPTEGRS | 1026 | Q9NW08 | |
| VRPAVPLLTQRGSGE | 551 | Q9Y4R7 | |
| VGSLGSRPPLSRLVV | 251 | Q9BW85 | |
| RRTVLPGLDGFQVRP | 411 | Q9BZ71 | |
| GNSILPERRGRPEIS | 966 | Q9BYW2 | |
| VPSSQRGPRRLSAEG | 556 | A7E2V4 | |
| QALGITIVRQPGRRG | 1931 | Q7Z7G8 | |
| PGVFLTQRRPSVGSQ | 1011 | Q9UPP1 | |
| GSPQALRQPGRARVA | 36 | Q6ICL7 | |
| RAREATRGPVVLPSQ | 906 | Q5SXM2 | |
| SRRSENRVVVSGLPP | 116 | Q07955 | |
| GPSVIRRGRRQSEPV | 471 | Q9H7P9 | |
| QGRVDRSRPQDTLGP | 1366 | Q92508 | |
| RRATRGGLRQVVAPP | 16 | P48556 | |
| TGLIENRPQSPATGR | 301 | Q92558 | |
| PQPVRTSRITIGGHR | 401 | Q9UNX4 | |
| RGRSPGQLQRPTGVA | 526 | Q9C040 | |
| VGGFRSLNPPLTIVR | 1926 | Q14669 | |
| QVVLGPSRGGRTTVR | 156 | Q9BZD7 | |
| RGRRLSPQTGTPGTT | 226 | Q8N7P7 | |
| RGRSPGQLQRPTGVA | 526 | O75382 | |
| TQVTPVPGGARLRTL | 216 | Q5T124 | |
| RESGGNLRLLSRPVP | 176 | Q8IZ26 | |
| SLRQRPEPQVTGTVG | 181 | O14773 | |
| PPEGRRKRTAVTGSQ | 91 | P0CJ85 | |
| VLPTGIPGRAVLERS | 566 | Q8N5Q1 | |
| IFGTPRARVILGSPR | 66 | P0DI83 |